From AI Factories to Pet Food
The week of May 11–15, 2026 delivered one of the more telling snapshots of the current private credit and asset-based finance market we’ve seen this quarter. Roughly $2.85 billion in announced facilities crossed the wires, spanning AI infrastructure, pharmaceuticals, crypto prime brokerage, specialty retail, pet food, modular rentals, mining services, and cold storage. The headline is no longer that private credit is growing, it’s that capital is moving toward increasingly specialized, collateral-rich, and milestone-structured transactions that look nothing like a vanilla cash-flow loan. For asset managers, allocators, and lenders trying to keep pace, the deal mix this week is a useful map of where the market is heading and where the operational and risk-management challenges are intensifying.
Lambda’s $1.0B Facility
The week’s largest transaction was J.P. Morgan’s $1.0 billion syndicated senior secured credit facility for Lambda, the AI cloud infrastructure company. The facility upsized Lambda’s prior $275 million line (originally established in August 2025), nearly a fourfold increase in roughly nine months.
Why it matters for asset management
- This is no longer venture-style risk. It’s a senior secured, GPU-collateralized, multi-tranche facility underwritten on contracted revenue from hyperscaler and enterprise AI customers. The financing economics – committed capital, lower blended cost of capital, oversubscribed syndicate – look much more like a traditional asset-backed lending stack than a tech loan.
- The pattern is now established: GPU fleets and data center capacity are being financed like specialty equipment leasing books, with hardware as collateral and customer contracts as cash-flow support.
Key risks to monitor
- Technology obsolescence: Next-generation NVIDIA accelerators ship on aggressive cycles; collateral value can compress quickly. Underwriting must price residual value carefully.
- Customer concentration: Hyperscaler-heavy revenue books are high quality but concentrated.
- Power and siting risk: Gigawatt-scale buildouts depend on grid availability and permitting timelines that have begun to slip in several US markets.
Opportunity
- Lenders willing to build the data and monitoring infrastructure to track GPU residual values, contract performance, and power utilization in near real-time will dominate this asset class for the next cycle. This is exactly the type of deal where a granular, data-driven loan management platform is no longer optional.
Ripple Prime’s $200MM from Neuberger
Neuberger Specialty Finance provided Ripple a $200 million asset-based debt facility to expand margin financing capacity at Ripple Prime – Ripple’s institutional prime brokerage platform acquired from Hidden Road in 2025.
Why it matters
- This is one of the largest debt facilities ever extended to a crypto-native prime broker, and it sits inside an established global asset manager’s specialty finance arm. The signal, that institutional capital is now structurally comfortable lending against a book of mixed traditional and digital asset margin loans, is significant.
- The structure is dynamic: drawable up to $200MM in tranches tied to underlying client borrowing demand. It mirrors the warehouse-style facilities that have long financed consumer and equipment lenders.
Key risks
- Asset volatility and haircuts: Mixing crypto and traditional collateral inside a single facility requires sophisticated, real-time margining and look-through reporting.
- Regulatory perimeter: US crypto rules continue to evolve; covenant design needs to flex with that.
Opportunity
- Specialty finance teams that can structure dynamically-advanced facilities with strong eligibility frameworks and real-time collateral reporting will lead this fast-growing segment. The line between “prime brokerage” and “asset-based lending” is officially blurred.
Aquestive Therapeutics and Oaktree, $150MM
Oaktree Capital Management refinanced Aquestive Therapeutics’s debt with a new $150 million life sciences facility. The structure is the story:
- $55MM funded at close (used to repay a prior $45MM loan).
- $20MM tranche unlocking on FDA approval of Anaphylm.
- $25MM tranche tied to sales milestones.
- Up to $50MM available with mutual consent.
- Interest-only through 2031 maturity.
Why it matters
This is a textbook example of how modern specialty lenders are pricing event-driven optionality directly into the capital stack. The borrower defers principal, lowers near-term cash outflow, and earns access to growth capital as clinical and commercial milestones de-risk. The lender, in turn, gets a structured exposure with embedded performance triggers.
Key risks
Regulatory binary risk (FDA approval), launch execution, and milestone interpretation disputes are the standard hazards. Documentation precision and milestone monitoring discipline are essential.
Opportunity
Tranched, milestone-linked facilities are spreading well beyond life sciences. Expect to see this design pattern in fintech, climate tech, and defense tech facilities over the next 12 months.
Phillips Pet Food, Guitar Center, Rango, and more
The week was particularly rich in classic ABL activity – the steady, collateral-driven lending that sits at the heart of the specialty finance market.
- Phillips Pet Food and Supplies closed a $175 million senior secured credit facility agented by Siena Lending Group (holding $105MM of the facility), refinancing existing debt and funding the acquisition of certain assets from Central Garden & Pet. A solid example of ABL stepping in to support a strategic M&A move in a defensive consumer category.
- Guitar Center amended and extended its existing ABL with Wells Fargo as administrative and collateral agent, maintaining $375 million in total commitments, lowering borrowing costs, relaxing minimum availability covenants, and pushing maturity from December 2027 to May 2031. A constructive sign for specialty retail credit.
- White Oak Commercial Finance provided a $25 million senior secured ABL facility to Rango, Inc., a mining services platform operating across 13 states (aggregates, precious metals, frac sand). Classic capital-intensive, working-capital-heavy ABL story.
- JPalmer Collective delivered a $3.5MM asset-based line to Pangaea Holdings in consumer products.
- Amerisource Business Capital provided a $2.0MM working capital facility to an undisclosed industrial services company.
- Culain Capital Funding extended a $5.0MM working capital facility to an undisclosed frozen food producer.
Why it matters for asset managers
- This is the bread and butter of the private credit market – collateral-rich, monitored, advance-rate-driven facilities to mid-market borrowers. The deal sizes vary, but the workflow is the same: borrowing base certificates, eligibility tests, ineligibles, dilution reserves, dominion accounts, field exams, and continuous monitoring. The lenders winning this market are the ones who can scale operational rigor without scaling headcount linearly.
Key risks
- Inventory and receivables aging discipline in consumer and retail names.
- Customer concentration in middle-market industrial businesses.
- Commodity exposure in mining and frozen food collateral.
Opportunity
- The middle market remains structurally underbanked, and the lenders that can deliver fast underwriting, automated borrowing base monitoring, and clear portfolio analytics are taking share from regional banks every quarter.
McGrath RentCorp’s $725MM Bank Syndicate
McGrath RentCorp completed a $725 million five-year revolving credit facility with Bank of America as Joint Lead Arranger, Sole Bookrunner, and Administrative Agent, with U.S. Bank and Wells Fargo as Joint Lead Arrangers and Co-Syndication Agents. It replaces a $650MM line, upsizes capacity by $75MM, and extends maturity to May 2031.
Why it matters
McGrath is a 35-year dividend grower with a deep rental asset base (modular buildings, portable storage, test equipment). The deal is a useful data point on bank syndicate appetite for high-quality, asset-rich, recurring-revenue businesses – even as private credit captures most of the headlines. Bank capital still wins where investment-grade-like profiles and large public-company sponsorship are in play.
Niche Specialty plays worth noting
- Post Road Group structured a $25MM tax lease facility for an industrial warehouse storage systems manufacturer, a reminder that tax-advantaged leasing structures remain a quietly powerful tool for equipment-intensive manufacturers.
- Encina Private Credit provided a $50MM first-out term loan to an undisclosed technology company. The first-out / last-out unitranche structure continues to be a workhorse for sponsored middle-market deals.
- Briar Capital Real Estate Fund delivered a $10.3MM real estate term loan for cold storage facilities, cold storage remains one of the more interesting structural growth themes in industrial real estate credit.
Takeaways for Asset Managers and Lenders
Step back from the individual deals and the week tells a coherent story.
- Specialization is the new alpha. Lambda, Ripple Prime, Aquestive, Rango, and the cold storage real estate deal each demanded different collateral expertise, different monitoring frameworks, and different covenant designs. Generalist lenders will continue to lose ground to specialists who understand the asset.
- Structure is doing more work than spread. Tranched commitments, milestone-linked tranches, dynamic advance rates, and amend-and-extend transactions dominated the week. Returns are increasingly being engineered through structure rather than headline pricing.
- Data and monitoring infrastructure are now the bottleneck. Whether you’re tracking GPU residuals, crypto margin haircuts, FDA milestone triggers, borrowing base eligibles, or modular rental utilization, the firms that can centralize, automate, and report on this data are dramatically more scalable than those that can’t.
- Bank capital and private credit are coexisting, not competing. McGrath got a bank syndicate. Lambda got a bank syndicate. Aquestive went to Oaktree. Phillips Pet Food went to Siena. Ripple went to Neuberger. The market is segmenting by borrower profile and collateral, not by a single “bank vs. non-bank” axis.
- Middle-market ABL is alive, deep, and rewarding operational discipline. The $2MM, $5MM, and $25MM ABL deals don’t make headlines, but in aggregate they’re an enormous and growing book of business, and they reward operational excellence more than any other segment.
How Cardo AI helps Asset Managers and Lenders
At Cardo AI, we build the operating system for private credit, asset-based finance, and structured finance – from data ingestion and loan tape standardization, through borrowing base and waterfall computation, through portfolio analytics and investor reporting. Our clients use Cardo AI to:
- Onboard new asset classes (from AI infrastructure to consumer ABL) without rebuilding from scratch.
- Automate borrowing base monitoring, eligibility testing, and covenant tracking.
- Run scenario, stress, and concentration analyses across portfolios in seconds, not days.
- Deliver institutional-grade reporting to investors, banks, and rating agencies.
The deals from last week are exactly the type of transactions our platform is built to support – at the scale, speed, and granularity that modern private credit demands.
Sources
ABL Advisor deal tables (May 11–15, 2026); company press releases via BusinessWire, GlobeNewswire, Bloomberg, Yahoo Finance, ABF Journal, Crowdfund Insider, and issuer investor relations pages.
If you’d like to see how Cardo AI can help your team operate at the next level, reach out to us and book a demo.